Comparing the effect of Cardiac Rehabilitation with usual care on Cardio_pulmonary function of patients with X syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015101024401N2

Enrollment

Registered

2016-06-26

Start date

2016-07-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Microvascular coronary syndrome. Anginal Syndrome

Interventions

Intervention 1: Control group: Routine medical treatment of cardiovascular risk factors including hyperlipidemia and hypertension. Intervention 2: Intervention: 12 sessions of cardiac rehabilitation i

Treatment - Drugs

Rehabilitation

Control group: Routine medical treatment of cardiovascular risk factors including hyperlipidemia and hypertension.

Intervention: 12 sessions of cardiac rehabilitation including 3 sessions per week with intensity of 40-60% hear rate reserve or the BORG scale of 11-15 for each session up to 60 minutes and routine me

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: The patients with angina pectoris; Abnormal perfusion scan; Normal angiogram with the coronary obstruction of below 50%; Receiving appropriate medical treatment. Typical or definite angina is sub-sternal chest discomfort that may radiate to the back, jaw, or arms, and/or symptoms which provoked by exertion or emotional stress and relieved by rest or nitroglycerin. Exclusion criteria: Acute coronary syndromes; Uncontrolled hypertension (resting systolic blood pressure > 180 mm Hg and/or resting diastolic BP > 110); Significant aortic stenosis (aortic valve area 1 20 beats per minutes); Third-degree atrioventricular (AV) block without pacemaker; Acute pericarditis or myocarditis; Decompensated heart failure; Acute systemic illness or fever; Severe orthopedic conditions that would prohibit exercise; Other metabolic conditions such as acute thyroiditis, hypokalemia, hyperkalemia, or hypovolemia (until adequately treated).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Maximal aerobic capacity. Timepoint: One month. Method of measurement: cardio_pulmonary exercise test.;Duck Score. Timepoint: One month. Method of measurement: Exercise test.	—

Secondary

Measure	Time frame
Ventilatory threshold. Timepoint: One month. Method of measurement: Cardio_pulmonary exercise test.;Duck questionaire. Timepoint: One month. Method of measurement: Cardio_pulmonary exercise test.;Recovery heart rate. Timepoint: One month. Method of measurement: Cardio_pulmonary exercise test.;Heart rate response. Timepoint: One month. Method of measurement: Cardio_pulmonary exercise test.;Exercise duration. Timepoint: One month. Method of measurement: Cardio_pulmonary exercise test.	—

Measure

Time frame

Ventilatory threshold. Timepoint: One month. Method of measurement: Cardio_pulmonary exercise test.;Duck questionaire. Timepoint: One month. Method of measurement: Cardio_pulmonary exercise test.;Recovery heart rate. Timepoint: One month. Method of measurement: Cardio_pulmonary exercise test.;Heart rate response. Timepoint: One month. Method of measurement: Cardio_pulmonary exercise test.;Exercise duration. Timepoint: One month. Method of measurement: Cardio_pulmonary exercise test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSepideh Niyazi

Tehran University of Medical Sciences

sepide.niyazi.sn @gmail+98 21 6119 2282

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026